At the ICSS, funds are being used TODAY to directly help patients by supporting some of the essential basic research used on autologous (our own) stem cells. In 2016, ICSS has collaborated with Chinese affiliates to support ground-breaking research on spinal cord injury using fat derived stem cells directly into the patient’s spinal cord with amazing results.
The ICSS also granted approval for a cancer study for patients with solid tumors, as well as an ALS study using a patient’s nucleated plasma. The ICSS has also continued supporting a study on the effects of concussion in rats to determine whether autologous stem cells mitigate the brain changes that are seen after head injury.
Moreover, as part of a serious commitment to community outreach, the ICSS has helped wounded warriors receive stem cell treatments at no cost.